Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Nivolumab (plattenepithelkarzinom des kopf-hals-nereichs): 2. Addendum zum auftrag A17-24; auftrag G17-10. [Nivolumab (squamous cell carcinoma of the head and neck). Second addendum to A-17-24] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 556. 2017 Indexing Status Subject indexing assigned by CRD MeSH Antibodies, Monoclonal; Carcinoma, Squamous Cell; Carcinoma, squamous cell of head and neck; Head and Neck Neoplasms; Humans; Neck; nivolumab Country of organisation Germany English summary There is no English language summary available. Address for correspondence IQWiG, Im Mediapark 8, DE-50670 Cologne, GERMANY, Tel: +49 (0) 221 - 35685 - 0, Fax: +49 (0) 221 - 35685 - 1 Email: berichte@iqwig.de AccessionNumber 32017000462 Date abstract record published 20/12/2017 |